Diagnosis of Human Cytomegalovirus Drug Resistance Mutations in Solid Organ Transplant Recipients—A Review
Authors:
Open Access
- 18 January 2024
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 14 (2) , 203
Abstract
Human cytomegalovirus (HCMV) infection may be asymptomatic in healthy individuals but can cause severe complications in immunocompromised patients, including transplant recipients. Breakthrough and drug-resistant HCMV infections in such patients are major concerns. Clinicians are first challenged to accurately diagnose HCMV infection and then to identify the most effective antiviral drug and determine when to initiate therapy, alter drug dosage, or switch medication. This review critically examines HCMV diagnostics approaches, particularly for immunocompromised patients, and the development of genotypic techniques to rapidly diagnose drug resistance mutations. The current standard method to identify prevalent and well-known resistance mutations involves polymerase chain reaction amplification of UL97, UL54, and UL56 gene regions, followed by Sanger sequencing. This method can confirm clinical suspicion of drug resistance as well as determine the level of drug resistance and range of cross-resistance with other drugs. Despite the effectiveness of this approach, there remains an urgent need for more rapid and point-of-care HCMV diagnosis, allowing for timely lifesaving intervention.Keywords
This publication has 46 references indexed in Scilit:
- Comparison between valganciclovir and aciclovir/valaciclovir for CMV prophylaxis in pediatric renal transplantationSaudi Journal of Kidney Diseases and Transplantation, 2015
- Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation SequencingJournal of Clinical Microbiology, 2013
- Next-generation sequencing technologies in diagnostic virologyJournal of Clinical Virology, 2013
- Cytomegalovirus disease in a renal transplant recipient: the importance of pre-transplant screening of the donor and recipientSaudi Journal of Kidney Diseases and Transplantation, 2013
- Cytomegalovirus Infections in Solid Organ Transplantation: A ReviewInfection & Chemotherapy, 2013
- Cytomegalovirus: pathogen, paradigm, and puzzleJournal of Clinical Investigation, 2011
- Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010
- A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypesAntiviral Research, 2010
- Frequency of UL97 Phosphotransferase Mutations Related to Ganciclovir Resistance in Clinical Cytomegalovirus IsolatesThe Journal of Infectious Diseases, 1995
- Analysis Of The Ul97 Phosphotransferase Coding Sequence In Clinical Cytomegalovirus Isolates And Identification Of Mutations Conferring Ganciclovir ResistanceThe Journal of Infectious Diseases, 1995